The current status of liver transplantation for primary hepatic malignancy. (Q34170288)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11232163%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

review article

1 reference

title

The current status of liver transplantation for primary hepatic malignancy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11232163%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

main subject

liver transplantation

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11232163%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Jordi Bruix

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11232163%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

Y Suarez

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11232163%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

A C França

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11232163%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J Fuster

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11232163%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 August 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11232163%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

published in

Clinics in liver disease

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11232163%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11232163%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11232163%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

591-605

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11232163%20AND%20SRC:MED&resulttype=core&format=json

Hepatitis C after orthotopic liver transplantation

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Hepatocellular carcinoma cells resist necrosis during anoxia by preventing phospholipase-mediated calpain activation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Prognostic factors in patients with hepatocellular carcinoma. Attempts for the selection of patients with prolonged survival

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Diagnostic value and tolerance of Lipiodol-computed tomography for the detection of small hepatocellular carcinoma: correlation with pathologic examination of explanted livers

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Prognostic factors of hepatocellular carcinoma in the west: a multivariate analysis in 206 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Fibrolamellar carcinoma of the liver: A tumor of adolescents and young adults with distinctive clinico-pathologic features

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Screening for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Hepatocellular carcinoma in Italian patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Asymptomatic hepatocellular carcinoma in Child's A cirrhosis. A comparison of natural history and surgical treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Rising incidence of hepatocellular carcinoma in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Resection of hepatocellular carcinomas. Results in 72 European patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Hepatocellular Carcinoma and Cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Cyclosporine induces cancer progression by a cell-autonomous mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Liver transplantation for hepatocellular carcinoma in patients without underlying liver disease: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Role of liver transplantation in cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Cirrhosis and the aetiology of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Intraarterial adriamycin and lipiodol for inoperable hepatocellular carcinoma: a comparison with intravenous adriamycin

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Prognosis of hepatocellular carcinoma: the BCLC staging classification

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Liver transplantation for small hepatocellular carcinoma: The tumor-node-metastasis classification does not have prognostic power

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Liver transplantation for primary hepatocellular carcinoma: tumor size and number determine outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Epithelioid hemangioendothelioma of the liver: a clinicopathologic study of 137 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Adult cirrhotic liver explants: precancerous lesions and undetected small hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Nodules of less-differentiated tumor within or adjacent to hepatocellular carcinoma: relative expression of transforming growth factor-alpha and its receptor in the different areas of tumor.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Liver transplantation for malignant disease. Results in 93 consecutive patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Predictive factors for postoperative recurrence of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Early recognition of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Role of liver transplantation in the treatment of unresectable liver cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Accuracy of radiology in detection of hepatocellular carcinoma before liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Familial Amyloidotic Polyneuropathy: domino liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Liver transplantation for hepatocellular carcinoma: the best treatment, but for which patient?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis-C-virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Serum hepatocyte growth factor levels in liver diseases: clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Performance status assessment in cancer patients. An inter-observer variability study

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: a pilot study in 20 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Risk factors for hepatocellular carcinoma among patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Liver transplantation for hepatocellular carcinoma: results with preoperative chemoembolization.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Tumor necrosis factor primes hepatocytes for DNA replication in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970128-8

7 January 2021

10.1016/S1089-3261(05)70128-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11232163%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference